Yuya Fujishima

1.8k total citations
49 papers, 1.2k citations indexed

About

Yuya Fujishima is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Yuya Fujishima has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Molecular Biology and 15 papers in Physiology. Recurrent topics in Yuya Fujishima's work include Adipokines, Inflammation, and Metabolic Diseases (17 papers), Adipose Tissue and Metabolism (9 papers) and Cardiovascular Disease and Adiposity (8 papers). Yuya Fujishima is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (17 papers), Adipose Tissue and Metabolism (9 papers) and Cardiovascular Disease and Adiposity (8 papers). Yuya Fujishima collaborates with scholars based in Japan, United States and Russia. Yuya Fujishima's co-authors include Iichiro Shimomura, Norikazu Maeda, Hitoshi Nishizawa, Tohru Funahashi, Shunbun Kita, Shiro Fukuda, Yoshimitsu Tanaka, Yoshinari Obata, Hirofumi Nagao and Shigeki Masuda and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Yuya Fujishima

46 papers receiving 1.2k citations

Peers

Yuya Fujishima

EPIDE

PHYSI

CCM

EDM

Shiro Fukuda Japan

Guangda Xiang China

Semon Wu Taiwan

Ming‐Sheng Teng Taiwan

Izumi Hashimoto Japan

Daniel Cuevas‐Ramos Mexico

Ayumu Hirata Japan

Tian Xu China

Momoko Horikoshi Japan

Reza Fadaei Iran

Shiro Fukuda Japan

Yuya Fujishima

425 ×1.0

339 ×0.8

EPIDE

284 ×0.8

PHYSI

194 ×0.8

CCM

131 ×0.7

EDM

Citations per year, relative to Yuya Fujishima Yuya Fujishima (= 1×) peers Shiro Fukuda

Countries citing papers authored by Yuya Fujishima

Since Specialization

Citations

This map shows the geographic impact of Yuya Fujishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuya Fujishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuya Fujishima more than expected).

Fields of papers citing papers by Yuya Fujishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuya Fujishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuya Fujishima. The network helps show where Yuya Fujishima may publish in the future.

Co-authorship network of co-authors of Yuya Fujishima

This figure shows the co-authorship network connecting the top 25 collaborators of Yuya Fujishima. A scholar is included among the top collaborators of Yuya Fujishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuya Fujishima. Yuya Fujishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuda, Shiro, Hitoshi Nishizawa, Yoshinari Obata, et al.. (2025). Association of Serum Soluble T-cadherin Levels with Metabolic Syndrome in Japanese Participants Undergoing Health Checkups. Journal of Atherosclerosis and Thrombosis.

Kita, Shunbun, Shiro Fukuda, Hirofumi Nagao, et al.. (2024). Soluble T-cadherin secretion from endothelial cells is regulated via insulin/PI3K/Akt signalling. Biochemical and Biophysical Research Communications. 732. 150403–150403. 2 indexed citations

Fujishima, Yuya, Hitoshi Nishizawa, Atsushi Tanaka, et al.. (2024). Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study. Journal of Atherosclerosis and Thrombosis. 32(4). 474–490. 2 indexed citations

Fukuda, Shiro, Yoshito Ito, Sachiko Tamba, et al.. (2024). Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admission. Endocrine Journal. 71(7). 705–711. 1 indexed citations

Fujishima, Yuya, Hitoshi Nishizawa, Takashi Nakamura, et al.. (2023). The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study. Biomedicines. 11(3). 674–674. 4 indexed citations

Nagao, Hirofumi, Hitoshi Nishizawa, Shiro Fukuda, et al.. (2023). Correlation between plasma glutamate and adiponectin in patients with type 2 diabetes. Endocrine Journal. 71(1). 55–63. 2 indexed citations

Fujishima, Yuya, Hitoshi Nishizawa, Takuro Saito, et al.. (2023). Changes in Eating Behaviors and Their Associations with Weight Loss in Japanese Patients Who Underwent Laparoscopic Sleeve Gastrectomy. Nutrients. 15(2). 353–353. 4 indexed citations

Fujishima, Yuya, Shunbun Kita, Hitoshi Nishizawa, Norikazu Maeda, & Iichiro Shimomura. (2023). Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome. Endocrine Journal. 70(7). 663–675. 8 indexed citations

Kita, Shunbun, Shiro Fukuda, Shuichi Otabe, et al.. (2023). Chronic hyperadiponectinemia induced by transgenic overexpression increases plasma exosomes without significantly improving glucose and lipid metabolism. Endocrine Journal. 70(6). 635–645. 2 indexed citations

10.

Kobayashi, Sachiko, Shunbun Kita, Daisuke Okuzaki, et al.. (2022). Favine/CCDC3 deficiency accelerated atherosclerosis and thrombus formation is associated with decreased MEF2C-KLF2 pathway. iScience. 25(11). 105252–105252. 6 indexed citations

11.

Kobayashi, Masaki, Yuka Nozaki, Yuya Fujishima, et al.. (2022). Individual evaluation of aging- and caloric restriction-related changes to distinct multimeric complexes of circulating adiponectin by immunoblotting. Experimental Gerontology. 164. 111821–111821. 1 indexed citations

12.

Fujishima, Yuya, Hitoshi Nishizawa, Takashi Nakamura, et al.. (2021). Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation. JCI Insight. 6(17). 20 indexed citations

13.

Fujishima, Yuya, Hitoshi Nishizawa, Hirofumi Nagao, et al.. (2020). Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment. Journal of Diabetes Investigation. 12(8). 1512–1520. 11 indexed citations

14.

Nakamura, Yuto, Shunbun Kita, Yoshimitsu Tanaka, et al.. (2020). Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice. Molecular Therapy. 28(10). 2203–2219. 127 indexed citations

15.

Fukuda, Shiro, Ayumu Hirata, Hitoshi Nishizawa, et al.. (2015). Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation. Cardiovascular Diabetology. 14(1). 8–8. 22 indexed citations

16.

Inoue, Kana, Norikazu Maeda, Yuya Fujishima, et al.. (2014). Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study. Diabetology & Metabolic Syndrome. 6(1). 95–95. 32 indexed citations

17.

Fujishima, Yuya, Norikazu Maeda, Keisuke Matsuda, et al.. (2014). Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion. Biochemical and Biophysical Research Communications. 444(2). 224–229. 14 indexed citations

18.

Yamaoka, Masaya, Norikazu Maeda, Seiji Nakamura, et al.. (2013). Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (Peripheral blood S100 mRNAs and metabolic syndrome). Biochemical and Biophysical Research Communications. 433(4). 450–455. 37 indexed citations

19.

Fujishima, Yuya, Norikazu Maeda, Kana Inoue, et al.. (2012). Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes. Cardiovascular Diabetology. 11(1). 107–107. 48 indexed citations

20.

Fujishima, Yuya, Masaki Ohsawa, Kazuyoshi Itai, et al.. (2011). Serum selenium levels are inversely associated with death risk among hemodialysis patients. Nephrology Dialysis Transplantation. 26(10). 3331–3338. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact